AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2010
May 19, 2010
34301_dirs_2010-05-19_27c8c48d-c94e-4d6d-9a4e-8a7c4b1f037a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-05-19
Reporting Person: HAWRAN PAUL W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-19 | Common Stock | P | 5000 | $4.8327 | Acquired | 55610 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 13